186 related articles for article (PubMed ID: 16368870)
1. Advances in the treatment of metastatic colorectal cancer.
Goldberg RM
Oncologist; 2005; 10 Suppl 3():40-8. PubMed ID: 16368870
[TBL] [Abstract][Full Text] [Related]
2. New systemic frontline treatment for metastatic colorectal carcinoma.
Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
Kelly H; Goldberg RM
J Clin Oncol; 2005 Jul; 23(20):4553-60. PubMed ID: 16002847
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J
J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725
[TBL] [Abstract][Full Text] [Related]
5. Advances in chemotherapy against advanced or metastatic colorectal cancer.
Omura K
Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
7. Is there a third-line therapy for metastatic colorectal cancer?
Grothey A
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S36-8. PubMed ID: 17178284
[TBL] [Abstract][Full Text] [Related]
8. [IFL].
Yamazaki K; Yoshino T; Boku N
Gan To Kagaku Ryoho; 2006 Jul; 33(7):907-10. PubMed ID: 16835478
[TBL] [Abstract][Full Text] [Related]
9. An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
Lee JJ; Chu E
Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma.
Hillner BE; Schrag D; Sargent DJ; Fuchs CS; Goldberg RM
Cancer; 2005 Nov; 104(9):1871-84. PubMed ID: 16177989
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
12. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
Uemura N; Yamada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
[TBL] [Abstract][Full Text] [Related]
13. The role of UFT in metastatic colorectal cancer.
Bennouna J; Saunders M; Douillard JY
Oncology; 2009; 76(5):301-10. PubMed ID: 19299903
[TBL] [Abstract][Full Text] [Related]
14. Third-line therapy for metastatic colorectal cancer.
Gundgaard MG; Soerensen JB; Ehrnrooth E
Cancer Chemother Pharmacol; 2008 Jan; 61(1):1-13. PubMed ID: 17786445
[TBL] [Abstract][Full Text] [Related]
15. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
Lin PC; Chen WS; Chao TC; Yang SH; Tiu CM; Liu JH
Cancer Chemother Pharmacol; 2007 Aug; 60(3):351-6. PubMed ID: 17111120
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.
Prescrire Int; 2006 Jun; 15(83):94-7. PubMed ID: 16764097
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy.
Stathopoulos GP; Rigatos SK; Malamos NA; Stathopoulos JG; Thallasinou P; Papazachariou E; Antoniou F; Kondopodis E; Xynotroulas J
Oncol Rep; 2004 Dec; 12(6):1295-300. PubMed ID: 15547753
[TBL] [Abstract][Full Text] [Related]
18. [A case of metastatic rectal cancer showing a sustained complete response to chemotherapy with FOLFIRI followed by UFT].
Tashima R; Yokoyama S; Yamashita Y; Baba K; Matsuda M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1663-6. PubMed ID: 17940386
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy.
Koukourakis G; Kouloulias V; Zacharias G; Koukourakis M
J BUON; 2010; 15(4):652-9. PubMed ID: 21229625
[TBL] [Abstract][Full Text] [Related]
20. Rapid evolution in colorectal cancer: therapy now and over the next five years.
de Gramont A
Oncologist; 2005 Oct; 10 Suppl 2():4-8. PubMed ID: 16272453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
